Breaking News

EMD Millipore, Singulex In SMC Technology Pact

Expands protein detection franchise

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

EMD Millipore, the Life Science business of Merck KGaA, and Singulex, a developer and provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, have entered a definitive agreement under which EMD Millipore will control and manage the Singulex Life Science Research business.   Singulex will receive an upfront payment, royalties and additional payments based on certain commercial milestones. EMD Millipore will have exclusive rights to further develop ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters